Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Medpace Holdings Inc (MEDP)

Medpace Holdings Inc (MEDP)
316.45 x 2 316.72 x 1
Post-market by (Cboe BZX)
316.61 -1.04 (-0.33%) 03/27/25 [NASDAQ]
316.45 x 2 316.72 x 1
Post-market 316.61 unch (unch) 16:00 ET
News & Headlines for Thu, Mar 27th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 316.61 (-0.33%)
FTRE : 8.36 (-1.07%)
AZTA : 35.52 (-2.44%)
RGEN : 137.12 (-1.66%)
CRL : 158.06 (-0.12%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
AZTA : 35.52 (-2.44%)
WST : 226.06 (+0.51%)
IQV : 179.36 (-0.37%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
RGEN : 137.12 (-1.66%)
AZTA : 35.52 (-2.44%)
IQV : 179.36 (-0.37%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 8.36 (-1.07%)
MEDP : 316.61 (-0.33%)
AZTA : 35.52 (-2.44%)
CRL : 158.06 (-0.12%)
IQV : 179.36 (-0.37%)
2 Reasons to Watch MEDP and 1 to Stay Cautious

2 Reasons to Watch MEDP and 1 to Stay Cautious

MEDP : 316.61 (-0.33%)
Why Medpace (MEDP) Shares Are Trading Lower Today

Why Medpace (MEDP) Shares Are Trading Lower Today

MEDP : 316.61 (-0.33%)
Medpace: Q4 Earnings Snapshot

Medpace: Q4 Earnings Snapshot

MEDP : 316.61 (-0.33%)
Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

Medpace (NASDAQ:MEDP) Posts Q4 Sales In Line With Estimates But Stock Drops

MEDP : 316.61 (-0.33%)
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect

MEDP : 316.61 (-0.33%)
AZTA : 35.52 (-2.44%)
IQV : 179.36 (-0.37%)
Charles River Laboratories Stock: Is CRL Underperforming the Healthcare Sector?

Charles River Laboratories has underperformed the healthcare sector over the past year, and analysts are cautious about the stock’s prospects.

MEDP : 316.61 (-0.33%)
XLV : 144.97 (+0.16%)
CRL : 158.06 (-0.12%)

Barchart Exclusives

Should You Buy the Dip in Rigetti Computing Stock in March 2025?
Rigetti Computing and other quantum computing stocks have been hit hard. So, is now the time to buy the dip? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies